Viralytics price has held steady as shown in his portfolio since June '08 - in a tumultuous market this is a great sign of a very tightly held stock as majority of investors like the progress of the trials and also with the company securing the overseas patents for their IP.
A high % of this stock is held by the biotech industry and are long term holders.
As stated before all the steps are being completed as they head towards involvement with large pharmaceuticals overseas in Europe & USA.
money magazine - david haselhurst's portfolio
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)